iANTHUS CAPITAL HOLDINGS (ITHUF) Cash from Operations (2020 - 2026)
iANTHUS CAPITAL HOLDINGS's (ITHUF) quarterly Cash from Operations came in at 1014000.0 in Q1 2026, down 67.51% year-on-year from 3121000.0 in Q1 2025, and down 46.63% quarter-over-quarter from 1900000.0 in Q4 2025.
iANTHUS CAPITAL HOLDINGS (ITHUF) Cash from Operations (2020 - 2026) Analysis & Trends
iANTHUS CAPITAL HOLDINGS has disclosed Cash from Operations across 7 years of filings, most recently posting 1014000.0 for Q1 2026.
- Cash from Operations for Q1 2026 came in at 1014000.0, down 67.51% year-over-year; the trailing twelve-month figure through Mar 2026 was 993000.0 (down 92.99% YoY), and the FY2025 annual result was 3100000.0, down 75.29% from the prior year.
- Cash from Operations came in at 1014000.0 for Q1 2026 at iANTHUS CAPITAL HOLDINGS, down from 1900000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 4797000.0 in Q3 2024 to a low of 8492000.0 in Q3 2022.
- The 5-year median for Cash from Operations is 1507000.0 (2024), against an average of 55235.29.
- Across the five-year window, Cash from Operations slumped 213.65% in 2022 and surged 291.49% in 2024, its largest moves.
- iANTHUS CAPITAL HOLDINGS's Cash from Operations stood at 5351000.0 in 2022, then soared by 80.64% to 1036000.0 in 2023, then surged by 279.15% to 1856000.0 in 2024, then rose by 2.37% to 1900000.0 in 2025, then sank by 46.63% to 1014000.0 in 2026.
- The last three Cash from Operations figures came in at 1014000.0 (Q1 2026), 1900000.0 (Q4 2025), and 5100000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -40.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 401.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 463.30 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 145.80 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 13.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -165.74 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 89.36 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 125.13 Mn |
| 10 | iANTHUS CAPITAL HOLDINGS | - | - | 15.92 Mn | 1.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.01 Mn |
| Mar 31, 2026 | 1.01 Mn |
| Dec 31, 2025 | 1.90 Mn |
| Dec 31, 2025 | 1.90 Mn |
| Sep 30, 2025 | -5.10 Mn |
| Sep 30, 2025 | -5.10 Mn |
| Jun 30, 2025 | 3.18 Mn |
| Jun 30, 2025 | 3.18 Mn |
| Mar 31, 2025 | 3.12 Mn |
| Mar 31, 2025 | 3.12 Mn |
| Dec 31, 2024 | 1.86 Mn |
| Dec 31, 2024 | 1.86 Mn |
| Sep 30, 2024 | 4.80 Mn |
| Sep 30, 2024 | 4.80 Mn |
| Jun 30, 2024 | 4.38 Mn |
| Jun 30, 2024 | 4.38 Mn |
| Mar 31, 2024 | 1.51 Mn |
| Mar 31, 2024 | 1.51 Mn |
| Dec 31, 2023 | -1.04 Mn |
| Dec 31, 2023 | -1.04 Mn |